Another full-regimen HIV pill enters the market: Triumeq

August 22, 2014 - Project Inform.

Convenient options for treating HIV infection got a boost today as the new all-in-one pill called Triumeq was approved by the FDA. Triumeq is a full HIV regimen made up of the three drugs dolutegravir (Tivicay), abacavir (Ziagen) and lamivudine (Epivir). Dolutegravir is an integrase inhibitor while the other two drugs are NRTIs, also available as Epzicom. Four full-regimen pills are now available as HIV treatment: Triumeq, Stribild, Complera and Atripla.

This is the first all-in-one HIV pill approved by the FDA without Truvada (tenofovir/emtricitabine), which makes it a new choice for those with impaired kidney function. Continue reading…

 

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name
Wed, 5/24/2017 - 1:47am
Wed, 5/24/2017 - 1:39am

The Well Project's picture

The Well Project liked the aglm_blog Intro - Imnobody

Tue, 5/23/2017 - 3:33pm

Learn how to care for yourself as you get tips about being ready to go back to work, what kind of work you want to do, and applying for jobs.

Obtener la información que necesita al iniciar el tratamiento - la elección de un régimen de medicamentos, adherencia, resistencia, de tomar las píldoras, los efectos secundarios, y mucho más

Read about the symptoms, diagnosis, and treatment of different fungal infections, including candidiasis, cryptococcus, histoplasmosis, and more.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>